SIO_379912-19_Fall_MC_WB_1277x205 (1).jpg

Master Class 2019

» Program

» Faculty

Registration

» Registration

Hotel

» Hotel

Meet the 2019 SIO Fall Master Class Faculty

The most esteemed interventional oncologists will present at SIO Master Class: Catheter Directed Therapy for the New IR/IO Practice this November 2-3 at the Radisson Blue Hotel in Chicago, Illinois, USA.

Register today for the opportunity to learn from these experts in the field!

 

Click a name below to read more about each speaker!

Course Directors

Michael C. Soulen, MD Michael C. Soulen, MD

University of Pennsylvania

Dr. Soulen received his BS from Yale University and MD from the University of Pennsylvania. He was then Resident and Chief Resident at The Johns Hopkins Hospital, followed by clinical and research Fellowships at Thomas Jefferson University. He joined the faculty at the University of Pennsylvania in 1991, where he is now Professor of Radiology & Surgery and Director of Interventional Oncology at the Abramson Cancer Center. His clinical practice focuses on image-guided therapies for hepatic malignancies, particularly metastatic neuroendocrine tumors. More than 200 publications reflect the evolution from pre-clinical research to his current focus on clinical trials. He is the principal investigator for the RETNET trial, the first randomized trial of standard embolization techniques for liver metastases. 

Dr. Soulen served on the board of the Society of Interventional Radiology (SIR) for 10 years and as Director for Research Education of the SIR Foundation for four years. He chaired the SIR Annual Scientific Meeting, as well as numerous other research and CME courses. He is on the Board of the Society of Interventional Oncology, where he served as annual meeting chair and board chair. He also serves on the Board of Directors for the North American Neuroendocrine Tumor Society, and is the Clinical Chair of the Radiological Society of North America (RSNA) Clinical Trials Methodology Workshop. He has served on the editorial boards of the major journals in the field, on NIH study sections for image-guided therapy, and reviews grants for multiple research foundations including RSNA, SIR, and SIO.

Sarah White, MD, MS Sarah White, MD, MS

Medical College of Wisconsin

Sarah B. White. MD,MS,FSIR, Associate Professor, Department of Radiology, Medical College of Wisconsin, Milwaukee-53226. Dr White is an interventional radiologist working on prelinical and clinical reserach in the area of interventional Oncology. She is also co-vice chairman of research in the Department of Radiology. Dr. White received research support from RSNA, SIR and indusdtry sponsored projects.

Speakers

Rony Avritscher, MD Rony Avritscher, MD

University of Texas MD Anderson Cancer Center

Dr. Rony Avritscher is an Associate Professor and co-chair of the pre-clinical research program in the Department of Interventional Radiology. Dr. Avritscher earned his medical degree from the University of Sao Paulo, in Sao Paulo, Brazil. He completed his radiology residency at the University of Texas Medical School at Houston and Interventional Radiology Fellowship at MD Anderson Cancer Center and subsequently joined the faculty in 2006. He is certified by the American Board of Radiology and holds a Certificate of Added Qualification in Interventional Radiology. His main research focus is in image-guided interventions for hepatocellular carcinoma and other liver cancers, including translational research in animal models of liver disease and catheter-based therapies. He is interested in innovative ways to enhance the efficacy of our minimally-invasive approaches and is the recipient of several grants to investigate image-guided minimally-invasive therapies in liver cancer. He established an independent laboratory and was the recipient of a prestigious individual investigator award from CPRIT (Cancer Prevention and Research Institute of Texas) with current focus on characterizing the heterogeneous nature of longitudinal changes of liver tumor immune microenvironment during treatment, as well as implementing novel molecular and imaging approaches to reduce disease recurrence. He is a current active member of the Society of Interventional Oncology and participates in the SIO research grant study section, as well as in the SIO research committee. Dr. Avritscher is the recipient of an SIO research grant for his work on the tumor immune microenvironment after transcatheter arterial embolization in hepatocellular carcinoma. He was recently elected a fellow of the Society of Interventional Radiology in 2018 and has been chairing diverse interventional oncology session workshops at the annual meeting of the Society of Interventional Radiology, including the sessions dedicated to catheter embolization. He is also a current member of the grant review committee for the Society of Interventional Radiology (SIR). Other interests include advanced hybrid suite imaging, lymphatic interventions, and cirrhosis. He received the Editor’s Award for Outstanding Laboratory Investigation from the Journal of Vascular and Interventional Radiology in 2014. He has authored over several original manuscripts, books, and abstracts, and has been an investigator in multiple clinical trials. 

Julius Chapiro, MD, PhD Julius Chapiro, MD, PhD

Yale University School of Medicine

Dr. Chapiro’s research focuses on developing new quantitative imaging biomarkers for the diagnosis, characterization, and therapeutic management of liver cancer. His translational research portfolio includes the development of novel embolic agents as well as the application of artificial intelligence and machine learning solutions for the assessment of liver cancer. His basic research interest mainly focuses on developing new tools to characterize the tumor microenvironment and the immune system in the setting of loco-regional, image-guided therapies of liver cancer. 

Creating innovative and clinically applicable imaging solutions for liver cancer with advanced molecular imaging, image post-processing and machine learning approaches and translating them to clinical practice has been his central mission for the past five years. He authored and co-authored >60 original research articles, numerous reviews and book chapters and gave more than 50 talks and invited lectures within the last four years. His research has also resulted in several filed patent applications, 510(k)-approved medical products and significant grant support from federal, foundational and industry sources. He is an active research mentor to more than 20 undergraduate, medical and graduate students as well as peers both at Yale and other national and international institutions. Being an active contributor, journal-, abstract- and grant reviewer in several professional societies (RSNA, SIR and SIO), he is also committed to education and the mission of disseminating research data and scientific knowledge. He is the co-initiator of the "Rising Star" Student Exchange Program in collaboration with the Charité University Hospital in Berlin and co-manages the Yale Interventional Oncologt laboratory. 

https://medicine.yale.edu/lab/radresearch/faculty/julius_chapiro.profile

Khashayar Farsad MD, PhD Khashayar Farsad MD, PhD

Oregon Health & Science University School of Medicine

Khashayar Farsad is Associate Professor of Interventional Radiology and Director of Research at the Dotter Interventional Institute. Dr. Farsad earned his MD and PhD degrees from Yale University.  He completed residency and fellowship training at Harvard Medical School and the Massachusetts General Hospital.  He is board-certified in Diagnostic Radiology and Vascular and Interventional Radiology.  Dr. Farsad is a Fellow of the Society of Interventional Radiology (FSIR), and actively serves on committees through the American Board of Radiology (ABR), the American Association of Digestive Disease Interventions (ASDDI), the Society of Interventional Radiology (SIR), and the American College of Radiology (ACR). Dr. Farsad’s primary academic interests are in the areas of oncology, portal hypertension and venous disease.

Nicholas Fidelman, MD Nicholas Fidelman, MD

University of California San Francisco

Coming Soon!

Ron Charles Gaba, MD, MS Ron Charles Gaba, MD, MS

University of Illinois Health

Ron C. Gaba, MD, MS, is an Associate Professor of Radiology and Pathology, Division Head of Interventional Radiology, Vice Head for Research in the Department of Radiology, and Director of Medical Student Research at the University of Illinois College of Medicine at Chicago. Dr. Gaba earned his medical degree from the University of Michigan in 2002, completed a Diagnostic Radiology residency at the University of Illinois at Chicago in 2007, and trained in Vascular and Interventional Radiology at Northwestern University in 2008 prior to joining the University of Illinois Department of Radiology, Division of Interventional Radiology in 2008. Dr. Gaba also completed an M.S. degree in Clinical and Translational Science in the University of Illinois School of Public Health in 2019. During his tenure at the University of Illinois, Dr. Gaba has maintained an active role in clinical service and patient care focused on the management of liver cancer using image-guided locoregional therapy, which has developed his clinical aptitude in multidisciplinary cancer care and management expertise for liver malignancies. Dr. Gaba’s extramurally (United States National Institutes of Health and Department of Defense) funded research—which investigates large animal models of liver disease and liver cancer, locoregional drug delivery approaches in the liver, and liver cancer genomics—supports a solid track record for academic productivity, spanning more than 160 peer-reviewed literature publications. Dr. Gaba has also contributed to the mentorship of medical students and trainees through the implementation of unique scholastic programs—including the Interventional Radiology Research Fellowship/Master of Science (M.S.) Program and the Department of Radiology Residency M.S. Program—which provide mentored pathways for the academic and professional development of young physician-scientists.

Ryan Hickey, MD Ryan Hickey, MD

NYU Langone Medical Center

Ryan Hickey, MD, FSIR, is the Director of Interventional Oncology and Transplant Interventional Services at NYU Langone Medical Center in New York, NY. He completed training in the DIRECT pathway at Northwestern University in Chicago, IL., where he subsequently served on the interventional radiology faculty for five years before moving to NYU in 2017. Areas of clinical and research focus include locoregional therapies for primary and metastatic hepatic malignancies and interventions for portal hypertension.

Kenneth J Kolbeck, MD, PhD Kenneth J Kolbeck, MD, PhD

Dotter Interventional Institute

Coming Soon!

David C. Madoff, MD David C. Madoff, MD

Yale School of Medicine

Dr. David C. Madoff is Vice Chair for Academic Affairs and Professor of Radiology at Weill Cornell Medicine and an Attending Physician at NewYork-Presbyterian/Weill Cornell. He is an internationally-recognized expert in Interventional Oncology, a subspecialty within Interventional Radiology that offers patients with various forms of cancer minimally invasive curative, adjuvant and palliative treatment options. Dr. Madoff earned his B.A. from Emory University and his M.D. from the University of Pittsburgh. He completed both his internship in Internal Medicine and residency in Radiology at SUNY at Stony Brook and his fellowship training in Vascular and Interventional Radiology at The University of Texas MD Anderson Cancer Center. Dr. Madoff achieved Board Certification in Diagnostic Radiology from the American Board of Radiology in 2000 and attained his Certificate of Added Qualifications in Vascular and Interventional Radiology in 2002. He was a faculty member in the Section of Interventional Radiology at MD Anderson Cancer Center in Houston, Texas for a decade before joining Weill Cornell in 2011. From January 2011 to November 2015, Dr. Madoff served as Chief of the Division of Interventional Radiology. Under his leadership, the division experienced tremendous growth clinically and academically and regained its prominence as one of the leading Divisions of Interventional Radiology in the nation.

Bill Saliba Majdalany, MD Bill Saliba Majdalany, MD

University of Michigan

After completing diagnostic radiology residency and vascular interventional radiology fellowship at Brigham and Women's Hospital/Harvard Medical School, Dr. Majdalany began his faculty career at The Ohio State University Wexner Medical Center. He was subsequently recruited to the University of Michigan as the Fellowship Director and he was instrumental in establishing the lymphatic intervention practice, growing loco-regional cancer treatment volume, and launching the first off-site IR clinic. In 2019, he joined the radiology faculty at Emory University as an Associate Professor and Program Director of the Integrated and Independent Vascular Interventional Radiology Residencies. His dominant clinical and research interests are in lymphatic intervention, hepatobiliary/portal/transplant interventions, and superficial/deep venous disease.

Gordon McLennan, MD Gordon McLennan, MD

Cleveland Clinic

Coming Soon!

Samdeep Mouli, MD Samdeep Mouli, MD

Northwestern University

I am an Assistant Professor in Interventional Radiology at Northwestern University's Feinberg School of Medicine. I specialize in research regarding imaging and treatment of primary liver cancer (hepatocellular carcinoma). I maintain a highly active clinical practice and a rapidly developing translational research program focused specifically upon the application of novel therapies in the setting of image-guided therapy for GI cancers. I am co-director of the Interventional Oncology Laboratory of Northwestern University’s Feinberg School of Medicine.I am an Assistant Professor in Interventional Radiology at Northwestern University's Feinberg School of Medicine. I specialize in research regarding imaging and treatment of primary liver cancer (hepatocellular carcinoma). I maintain a highly active clinical practice and a rapidly developing translational research program focused specifically upon the application of novel therapies in the setting of image-guided therapy for GI cancers. I am co-director of the Interventional Oncology Laboratory of Northwestern University’s Feinberg School of Medicine.

Gregory J. Nadolski, MD Gregory J. Nadolski, MD

University of Pennsylvania

Coming Soon!

Bruno C. Odisio, MD Bruno C. Odisio, MD

Anderson Cancer Center

Dr. Odisio is Associate Professor and Co-Director of Research at the Department of Interventional Radiology, Division of Diagnostic Imaging. Dr. Odisio’s main area of clinical and research interest is the use of loco-regional therapies for the treatment and palliation of primary and secondary liver malignancies. Additionally, Dr. Odisio also investigates the use of advanced imaging technologies for improving and predicting outcomes after minimally invasive procedures, as well its potential use in combination with surgical procedures.

Alda Tam, MD Alda Tam, MD

University of MD Anderson Cancer Center

Alda Tam is an Associate Professor in the Department of Interventional Radiology at the University of Texas M.D. Anderson Cancer Center. She received a BScH from Brown University and her MD from the University of British Columbia. She completed a diagnostic radiology residency and MBA at the University of Southern California, and a fellowship in Vascular and Interventional Radiology at the University of Texas M.D. Anderson Cancer Center. She is an active interventional oncologist with involvement in both translational research and clinical trials. Her clinical interests include the treatment of bone metastases, minimally invasive palliative therapies, and optimizing biopsy yield for clinical trials. Her research interests include exploring novel ablative technologies in combination with nanotechnology for the treatment of bone metastases. She is an inducted fellow of the Society of Interventional Radiology (SIR) and the current Division Councilor who directs the development of standards and guidelines.

Jordan Tasse, MD Jordan Tasse, MD

Rush University Medical Center

Coming Soon!

William S Rilling, MD William S Rilling, MD

Medical College of Wisconsin/Frodtert Hospital

Medical College of Wisconsin/Frodtert Hospital William S. Rilling, MD FSIR is Professor of Radiology and Surgery at the Medical College of Wisconsin. He completed his diagnostic radiology residency at the Medical College of Wisconsin and his Fellowship in Vascular Interventional Radiology at Northwestern University in Chicago in 1996. He has been practicing at the Medical College of Wisconsin since 1996 and is the Vice Chair of Clinical Operations in Radiology and the former Director of the Division of Vascular and Interventional Radiology for 14 years. Dr. Rilling has served on the Executive Council for the Society of Interventional Radiology (SIR), and the Board of Directors for both World Congress of Interventional Oncology (WCIO) and SIR Foundation. As Education councilor for SIR, he co-directed the first three professional education meetings dedicated to Interventional Oncology beginning in 2002. He has also served as annual meeting chair for both SIR and WCIO. He has served as local and national principal investigator for a number of important IO trials and is currently active as a consultant for a number of companies working to improve outcomes in IO.

Michael C. Soulen, MD Michael C. Soulen, MD

University of Pennsylvania

Dr. Soulen received his BS from Yale University and MD from the University of Pennsylvania. He was then Resident and Chief Resident at The Johns Hopkins Hospital, followed by clinical and research Fellowships at Thomas Jefferson University. He joined the faculty at the University of Pennsylvania in 1991, where he is now Professor of Radiology & Surgery and Director of Interventional Oncology at the Abramson Cancer Center. His clinical practice focuses on image-guided therapies for hepatic malignancies, particularly metastatic neuroendocrine tumors. More than 200 publications reflect the evolution from pre-clinical research to his current focus on clinical trials. He is the principal investigator for the RETNET trial, the first randomized trial of standard embolization techniques for liver metastases. 

Dr. Soulen served on the board of the Society of Interventional Radiology (SIR) for 10 years and as Director for Research Education of the SIR Foundation for four years. He chaired the SIR Annual Scientific Meeting, as well as numerous other research and CME courses. He is on the Board of the Society of Interventional Oncology, where he served as annual meeting chair and board chair. He also serves on the Board of Directors for the North American Neuroendocrine Tumor Society, and is the Clinical Chair of the Radiological Society of North America (RSNA) Clinical Trials Methodology Workshop. He has served on the editorial boards of the major journals in the field, on NIH study sections for image-guided therapy, and reviews grants for multiple research foundations including RSNA, SIR, and SIO.

Sarah White, MD, MS Sarah White, MD, MS

Medical College of Wisconsin

Sarah B. White. MD,MS,FSIR, Associate Professor, Department of Radiology, Medical College of Wisconsin, Milwaukee-53226. Dr White is an interventional radiologist working on prelinical and clinical reserach in the area of interventional Oncology. She is also co-vice chairman of research in the Department of Radiology. Dr. White received research support from RSNA, SIR and indusdtry sponsored projects.

David A Woodrum, MD, PhD David A Woodrum, MD, PhD

Mayo Clinic

To practice my clinical specialty, Interventional Radiology emphasizing oncologic therapy and MRI-guided interventions, I have trained in medicine, clinical diagnostic and interventional radiology, MRI-guided intervention, physics and cell biology. My clinical residency and fellowship were performed at Mayo Clinic in Rochester, MN, with several additional months spent at Northwestern University and Johns Hopkins for further training in interventional MRI techniques. I was then offered a staff position at Mayo Clinic to advance interventional MRI clinical applications. At that time, we had MR-guided focused ultrasound for uterine fibroids. Since then we have added MR compatible biopsy and ablation devices, such as laser ablation and cryoablation technology for treatment of HCC and prostate cancer. We are pursuing clinical applications of many different MR compatible technologies to determine where it makes sense for clinical implementation. With my clinical collaborators, our goal is to provide better and new treatment options for patients with HCC and other solid organ malignancies. 

MR guided Laser Ablation and Cryoablation for the prostate cancer. Prostate cancer is the most common cancer among men. Standard therapies of surgery and radiation can have significant morbidity and recurrence rates range from 20-30%. Native and recurrent prostate cancer are best visualized with MR imaging. MR guided focal laser ablation is feasible and short term results demonstrate excellent results. MRI guided focal laser therapy and focal cryoablation are increasingly being utilized in native prostate cancer especially for low grade cancer and recurrent prostate cancer patients. Increasingly, patients are demanding for less morbid easy ways to treat these small cancers. Focal therapy is rapidly becoming that option. Our goal is to continue to expand our treatment capabilities in the fight against cancer. 

Hooman Yarmohammadi, MD Hooman Yarmohammadi, MD

Memorial Sloan Kettering Cancer Center

I received my MD degree from the Shiraz University of Medical Sciences in Shiraz, Iran. Following graduation from medical school I served as a general practitioner in Shiraz. I was a general surgery resident from 2002-2006 at the Shiraz University of Medical Sciences. Afterwards, I relocated to the United States in 2006 as a post-doctoral research fellow. I did a year of general surgery internship at the University of Pennsylvania Health System from 2007-2008, and then completed a diagnostic radiology residency at University Hospitals, Case Medical Center, Cleveland, Ohio from 2008-2012. I subsequently completed a fellowship in interventional radiology at Johns Hopkins Medical Center in Baltimore, Maryland in 2013. I have authored or co-authored 48 peer-reviewed publications, 7 as first author, in addition to two reviews and two book chapter. Currently I am working as an assistent Professor in Radiology in the Interventional Radiology Service at MSKCC. I am very interested in Research and particularly on Malignant Ascites and its managment.